References
- Cohen G. M., Mannering G. J. Involvement of a hydrophobic site in the inhibition of the microsomal p-hydroxylation of aniline by alcohols. Molecular Pharmacology 1973; 9: 383–397
- Gonzalez J. The molecular biology of cytochrome P450s. Pharmacology Reviews 1989; 40: 243–288
- Hansel R., Wohlfart R., Schmidt H. Nachweis sedativ-hypnotischer Wirkstoffe im Hopfen. 3. Mitteilung: Der Gehalt von Hopfen und Hopfenzubereitungen an 2-Methyl-3-buten-2-ol. Plant Medica 1982; 45: 224–228
- Iba M. M., Gander J. E., Mannering G. J. Lipid peroxidation-cytochrome P450 interactions. Use of linoleic acid hydroperoxide in the characterization of the spin stete of membrane-bound P450. Xenobiotica 1993; 23: 227–239
- Jeffery E. H., Mannering G. J. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Molecular Pharmacology 1933; 23: 748–757
- Kitada M., Komori M., Ohi H., Imaoka Y. S., Funae Y., Kamataki T. Form-specific degradation of cytochrome P-450 by lipid peroxidation in rat liver microsomes. Research Communications in Chemical Pathology and Pharmacology 1989; 63: 175–187
- Mannering G. J., Deloria L. B., Shoeman J. A., Nutter L. M. Effects of the hop component, colupulone, on the induction of cytochrome P4503A and the replication of human tumour cells. Food, Nutrition and Chemical Toxicity, D. V. Parke, C. Ioannides, R. Walker. Nishimura Company Ltd (Smith-Gordon), Japan 1993; 311–322
- Mannering G. J., Shoeman J. A., Deloria L. B. Identification of the antibiotic hops component, colupulone, as an inducer of hepatic cytochrome P4503A in the mouse. Drug Metabolism and Disposition 1992; 20: 142–147
- Nebert W., Gonzalez F. J. P450 genes: structure, evolution, and regulation. Annual Reviews of Biochemistry 1987; 56: 945–993
- Ortiz de Montellano P. R. Alkenes and alkynes. Bioactivation of Foreign Compounds, M. W. Anders. Academic, Orlando 1985; 121–155
- Ortiz de Montellano P. R., Correia M. A. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annual Reviews in Pharmacology and Toxicology 1983; 23: 481–503
- Rettie A. E., Boberg M., Rettenmeier A. W., Baillie T. A. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Journal of Biological Chemistry 1988; 263: 13733–13738
- Rettie A. E., Rettenmeier A. W., Howald W. N., Baillie T. A. Cytochrome P-450-catalyzed formation of Δ4- VPA, a toxic metabolite of valproic acid. Science 1987; 235: 890–893
- Trush M. A., Kensler T. W. T. W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radicals in Biology and Medicine 1991; 10: 201–209
- Wohlfart R., Hansel R., Schmidt H. Nachweis sedativ-hypnotischer Wirkstoffe im Hopfen. 4. Mitteilung: Die Pharmakologie des Hopfeninhaltsstoffes 2-methyl-3-buten-2-ol. Journal of Medicinal Plant Research 1983a; 48: 120–123
- Wohlfart R., Wurm G., Hansel R., Schmidt H. Der Abbau der Bittersauren zum 2-Methyl-3-buten-2-ol, einem Hopfeninhaltsstoff mit sedativ-hypnotischer Wirkung. Archiv der Pharmazie 1983b; 316: 132–137